CRM vs MRK: Which Is the Better Buy?
Side-by-side comparison of Salesforce, Inc. and Merck & Co., Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-20.
Salesforce, Inc. · Technology
$182.14
+45.0% upside to fair value
Grade B
High Quality
VS
Merck & Co., Inc. · Healthcare
$114.27
+3.3% upside to fair value
Grade C
High Quality
QuantHub Verdict
CRM has more upside to fair value
(+45.0%).
MRK trades at a lower forward P/E
(22.4x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
CRM |
MRK |
| Current Price |
$182.14 |
$114.27 |
| Fair Value Estimate |
$264.10 |
$118.00 |
| Upside to Fair Value |
+45.0%
|
+3.3%
|
| Market Cap |
$173.0B |
$282.2B |
| Forward P/E |
22.8x
|
22.4x
|
| EV / EBITDA |
14.4x
|
13.5x
|
| Price / Sales |
4.2x
|
4.3x
|
| Price / FCF |
12.0x
|
20.2x
|
| Revenue Growth YoY |
+12.1%
|
+5.0%
|
| Gross Margin |
77.7%
|
81.9%
|
| Operating Margin |
21.5%
|
27.5%
|
| Return on Equity |
12.4%
|
5.6%
|
| Dividend Yield |
0% |
2.91% |
| FCF Yield |
8.33%
|
4.95%
|
| Analyst Consensus |
Buy
|
Overweight
|
Investment Thesis
Salesforce, Inc. is a leading enterprise software company specializing in cloud-based customer relationship management and enterprise applications. The company benefits from a durable competitive moat anchored by pioneering SaaS delivery, a large and growing customer base, and a diversified revenue mix with Service Cloud as the largest segment generating $9.05 billion in FY2025. Salesforce exhibi…
Merck delivered a clean Q1 2026 operational beat on April 30, with revenue of 16.3 billion dollars growing 5 percent year over year and Keytruda sales rising 12 percent to 8.0 billion dollars. The reported loss of 1.28 dollars per share, though better than the negative 1.47 dollar consensus estimate, reflected a 3.62 dollar per share IPR and D charge tied to the Cidara Therapeutics acquisition an…
Accumulation Zones
| Metric |
CRM |
MRK |
| Zone Low |
$198.08 |
$88.50 |
| Zone High |
$224.49 |
$100.30 |
| In Buy Zone? |
Yes
|
No
|